2048. Comparative Phylogenomic Analysis of Escherichia coli ST131 Isolates and IncF-type Plasmids from North Carolina Community Hospitals and Other Regions of the United States
Session: Poster Abstract Session: Diagnostics - Bacterial Identification & Resistance
Saturday, October 7, 2017
Room: Poster Hall CD
Posters
  • 20170922ST131_IDWeek2017.pdf (1.4 MB)
  • Background: Escherichia coli sequence type 131 (ST131), associated with CTX-M-15-type extended-spectrum b-lactamases (ESBLs), predominates globally among multidrug-resistant (MDR) E. coli. Among MDR E. coli ST131 isolates from North Carolina and other US regions, we explored genetic associations of the H30Rx and H30R1 subclones with IncF-type plasmid variants.

    Methods: Sequence data from 144 clinical E. coli isolates, including 39 MDR ST131 isolates from our 7 NC community hospitals and previous 104 ST131 isolates from other US regions, were analyzed and compared. Specific genes were sought using a bioinformatic pipeline at the Center for Genomic Epidemiology and BLAST. Evolutionary analyses were performed using MEGA7. Plasmid incompatibility groups and its STs were identified using PlasmidFinder and pMLST. Comparisons of the completed sequences of 2 ST131 reference plasmids with 144 ST131 draft genome assemblies were performed using CGView Comparison Tool, and circular comparison maps were generated. Among 31 blaCTX-M-containing contigs, blaCTX-M gene insertion sites were examined.

    Results: In the core genome phylogeny, the H30R1 and H30Rx clades were placed within a larger H30R clade (Fig. 1). pMLST revealed association of IncF[F2:A1:B-] plasmids (mostly blaCTX-M-15-positive) with H30Rx, and IncF[F1:A2:B20] plasmids (all blaCTX-M-15-negative) with H30R1. The ST131-associated IncF[F2:A1:B-] plasmids from NC generally resembled those from other US regions (Fig. 2). However, in contrast to the others, some of the NC plasmids lacked regions previously described as gisland 1h and/or the gColla-region,h in addition to gisland 2h (Fig. 3). Among the 31 NC ST131 isolates producing CTX-M (26 H30Rx and 5 H30R1 isolates), blaCTX-M-15 was inserted at the same chromosomal site in 3 H30Rx isolates, at different chromosomal sites in 3 H30Rx isolates, and on IncF plasmids in 1 H30Rx and 1 H30R1 isolates, suggesting that the blaCTX-M-containing gene cassette has moved around among and/or within these strains.

    Conclusion: Our genomic and plasmid analysis of community hospital-source ST131 isolates demonstrated fixation and ongoing evolution of specific plasmids within the separate but closely related H30Rx and H30R1 sublineages.

    Hajime Kanamori, MD, PhD, MPH1,2, Timothy Johnson, PhD3, Christian Parobek, PhD4, Jonathan Juliano, MD, MSPH2, James R. Johnson, MD5, Brian D. Johnston, BA6, David J. Weber, MD, MPH, FIDSA, FSHEA7, William A. Rutala, PhD, MPH2 and Deverick Anderson, MD, MPH, FSHEA, FIDSA8, (1)Hospital Epidemiology, University of North Carolina Health Care, Chapel Hill, NC, (2)Division of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, NC, (3)University of Minnesota, Saint Paul, MN, (4)University of North Carolina School of Medicine, Chapel Hill, NC, (5)Infectious Diseases and International Medicine, University of Minnesota, Minneapolis, MN, (6)Minneapolis Veterans Affairs Health Care System, Minneapolis, MN, (7)Medicine, Pediatrics, Epidemiology, University of North Carolina, School of Public Health, Chapel Hill, NC, (8)Duke University Medical Center, Durham, NC

    Disclosures:

    H. Kanamori, None

    T. Johnson, None

    C. Parobek, None

    J. Juliano, None

    J. R. Johnson, Crucell/Janssen: Consultant , Consulting fee
    Merck: Grant Investigator , Grant recipient
    Tetraphase: Grant Investigator , Research grant
    Actavis/Allergan: Grant Investigator , Grant recipient

    B. D. Johnston, None

    D. J. Weber, None

    W. A. Rutala, None

    D. Anderson, None

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.